Article(id=1325224538853745040, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325224446230934140, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2026.02.007, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1758988800000, receivedDateStr=2025-09-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1793887751544, onlineDateStr=2026-11-05, pubDate=1770652800000, pubDateStr=2026-02-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1793887751544, onlineIssueDateStr=2026-11-05, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1793887751544, creator=13701087609, updateTime=1793887751544, updator=13701087609, issue=Issue{id=1325224446230934140, tenantId=1146029695717560320, journalId=1319690329412173987, year='2026', volume='47', issue='2', pageStart='107', pageEnd='212', issueExtLink='null', onlineDate='null', pubDate='1770652800000', pubDateStr='2026-02-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1793887729460, creator='13701087609', updateTime=1793934840172, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1325422043109400703, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325224446230934140, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1325422043109400704, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1325224446230934140, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=157, endPage=163, ext={EN=ArticleExt(id=1325224539071848849, articleId=1325224538853745040, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Effect of Huatan Huoxue decoction on multiple myeloma of phlegm-stasis obstruction type and its influence on SFRP3 and GRP78, columnId=1325221089055486019, journalTitle=World Clinical Drug, columnName=Article, runingTitle=null, highlight=null, articleAbstract=
Objective

To investigate the efficacy of Huatan Huoxue decoction on multiple myeloma(MM) of phlegm-stasis obstruction type and its influence on secreted frizzled related protein(SFRP) 3 and glucose regulatory protein(GRP) 78.

Methods

The patients with MM admitted to Lianshui county central hospital from January 2022 to December 2024 were selected as the research subjects. They were randomly divided into the observation group(62 cases, treated with chemotherapy+ilarradine+Huatan Huoxue decoction) and the control group(61 cases, treated with chemotherapy+ilarradine) using the simple random method. Both groups were treated continuously for 3 cycles. The main indicator of this study was the clinical total effective rate. The secondary indicators included the levels of SFRP3, GRP78 and inflammatory factors after 1 and 3 cycles of treatment, as well as the visual analogue scale(VAS) for pain, Karnofsky performance status(KPS), and activity of daily living(ADL) scale after 3 cycles of treatment. The safety indicator was the incidence of adverse reactions.

Results

The total effective rate of the observation group was significantly higher than that of the control group(93.55% vs. 80.33%, P<0.05). After 1 and 3 cycles of treatment, the serum levels of SFRP3 and GRP78 in both groups were lower than those before treatment(P<0.05), and the levels in the observation group were lower than those in the control group(P<0.05). The serum levels of interleukin(IL)-6, IL-17 and transforming growth factor-β in both groups were lower than those before treatment(P<0.05), and the levels in the observation group were lower than those in the control group(P<0.05). After 3 cycles of treatment, the VAS scores of both groups were lower than those before treatment(P<0.05), and the score of the observation group was lower than that of the control group(P<0.05). The KPS and ADL scores of both groups were higher than those before treatment(P<0.05), and the scores of the observation group were higher than those of the control group(P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group(P<0.05).

Conclusion

The formula for resolving phlegm and promoting blood circulation can help alleviate symptoms, delay disease progression, improve SFRP3, GRP78 and inflammatory factors levels, withoutt increasing the incidence of adverse reactions in patients with phlegm stasis obstruction type MM.

, authors=Fang QIAN1, Anwei DAI2, *, authorsList=Fang QIAN, Anwei DAI, authorCompany=null, correspAuthors=Anwei DAI, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1325224539302535570, articleId=1325224538853745040, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=化痰活血方治疗痰瘀痹阻型多发性骨髓瘤的效果及对分泌型卷曲相关蛋白、葡萄糖调节蛋白的影响分析, columnId=1325221089235841093, journalTitle=世界临床药物, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=
目的

探讨化痰活血方治疗痰瘀痹阻型多发性骨髓瘤(multiple myeloma,MM)的效果及对分泌型卷曲相关蛋白(secreted frizzled related protein,SFRP)3、葡萄糖调节蛋白(glucose regulatory protein,GRP)78的影响。

方法

选择2022年1月至2024年12月涟水县中医院收治的MM患者作为研究对象,以简单随机法分为观察组62例(化疗+来那度胺+化痰活血方)和对照组61例(化疗+来那度胺)。两组均连续治疗3个周期。本研究主要指标为临床总有效率;次要指标包含治疗1及3个周期后的SFRP3、GRP78及炎症因子水平,以及治疗3个周期后的疼痛视觉模拟评分(visual analogue scale,VAS)、卡氏功能状态评分(Karnofsky performance status,KPS)、日常生活活动(activity of daily living,ADL)量表;安全性指标为不良反应发生率。

结果

观察组治疗总有效率为明显高于对照组(93.55% vs. 80.33%,P<0.05)。治疗1及3个周期后,两组血清SFRP3、GRP78水平均较治疗前降低(P<0.05),且观察组低于对照组(P<0.05);两组血清白介素(interleukin,IL)-6、IL-17、转化生长因子-β水平均较治疗前降低(P<0.05),且观察组低于对照组(P<0.05)。治疗3个周期后,两组VAS评分均较治疗前降低(P<0.05),且观察组低于对照组(P<0.05),KPS及ADL评分均较治疗前升高(P<0.05),且观察组高于对照组(P<0.05)。观察组不良反应发生率低于对照组(P<0.05)。

结论

化痰活血方可帮助痰瘀痹阻型MM患者症状缓解,延缓疾病进展,改善SFRP3、GRP78及炎症因子水平,且不增加不良反应发生率。

, authors=钱芳1, 戴安伟2, *, authorsList=钱芳, 戴安伟, authorCompany=null, correspAuthors=戴安伟, authorNote=

钱芳,副主任中医师,研究方向:中医中药治疗肿瘤疾病研究。

, correspAuthorsNote=
戴安伟,主任中医师,研究方向:中医中药治疗疾病研究。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=XkpHdDgHIcTDsO1NmSKi3Q==, magXml=1OYp8Gy3HR7xZtRyGSuLjg==, pdfUrl=null, pdf=AACxP5Nyv4mEDFzGHlpmJQ==, pdfFileSize=1006775, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=M7YqXTjk9A6/qILnBAWdVw==, mapNumber=null, fund=null)}, authors=[Author(id=1325224539730354586, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224539814240668, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, authorId=1325224539730354586, language=EN, stringName=Fang QIAN, firstName=Fang, middleName=null, lastName=QIAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Oncology, Lianshui County Central Hospital, Huai'an 223400, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224539889738141, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, authorId=1325224539730354586, language=CN, stringName=钱芳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.涟水县中医院肿瘤科,江苏 淮安 223400, bio={"content":"

钱芳,副主任中医师,研究方向:中医中药治疗肿瘤疾病研究。

"}, bioImg=null, bioContent=

钱芳,副主任中医师,研究方向:中医中药治疗肿瘤疾病研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224539524833683, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, xref=1., ext=[AuthorCompanyExt(id=1325224539537416596, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539524833683, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Oncology, Lianshui County Central Hospital, Huai'an 223400, Jiangsu Province, China), AuthorCompanyExt(id=1325224539545805205, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539524833683, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.涟水县中医院肿瘤科,江苏 淮安 223400)])]), Author(id=1325224539982012831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325224540061704609, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, authorId=1325224539982012831, language=EN, stringName=Anwei DAI, firstName=Anwei, middleName=null, lastName=DAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Oncology, Kunshan Central Hospital, Kunshan 215300, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224540162367906, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, authorId=1325224539982012831, language=CN, stringName=戴安伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.昆山市中医院肿瘤科,江苏 昆山 215300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224539625496982, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, xref=2., ext=[AuthorCompanyExt(id=1325224539633885591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539625496982, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Kunshan Central Hospital, Kunshan 215300, Jiangsu Province, China), AuthorCompanyExt(id=1325224539642274200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539625496982, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.昆山市中医院肿瘤科,江苏 昆山 215300)])])], keywords=[Keyword(id=1325224540288197027, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, language=EN, orderNo=1, keyword=multiple myeloma), Keyword(id=1325224540397248932, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, language=EN, orderNo=2, keyword=Huatan Huoxue decoction), Keyword(id=1325224540481135013, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, language=EN, orderNo=3, keyword=chemotherapy), Keyword(id=1325224540539855270, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, language=EN, orderNo=4, keyword=secreted frizzled related protein 3), Keyword(id=1325224540602769831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, language=EN, orderNo=5, keyword=glucose regulatory protein 78), Keyword(id=1325224540686655912, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, language=CN, orderNo=1, keyword=多发性骨髓瘤), Keyword(id=1325224540837650857, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, language=CN, orderNo=2, keyword=化痰活血方), Keyword(id=1325224540913148330, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, language=CN, orderNo=3, keyword=化疗), Keyword(id=1325224540988645803, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, language=CN, orderNo=4, keyword=分泌型卷曲相关蛋白3), Keyword(id=1325224541064143276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, language=CN, orderNo=5, keyword=葡萄糖调节蛋白78)], refs=[Reference(id=1325224542758642093, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=王国蓉, 杨光忠, 耿传营, 等. 依托泊苷联合G-CSF与环磷酰胺联合G-CSF在多发性骨髓瘤患者中进行自体外周血干细胞动员的比较[J]. 中华血液学杂志, 2024, 45(4): 351-356., articleTitle=null, refAbstract=null), Reference(id=1325224542938997166, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=谢适意, 于珍, 魏晓晶, 等. 细胞周期蛋白依赖性激酶4/6抑制剂对多发性骨髓瘤细胞B细胞成熟抗原和程序性死亡受体配体1表达的影响[J]. 中华实用诊断与治疗杂志, 2024,38(6): 546-551., articleTitle=null, refAbstract=null), Reference(id=1325224543010300335, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=HANAMURA I. Multiple myeloma with high-risk cytogenetics and its treatment approach[J]. Int J Hematol, 2022, 115(6): 762-777., articleTitle=null, refAbstract=null), Reference(id=1325224543089992112, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=BLADE J, BEKSAC M, CAERS J, et al. Extramedullary disease in multiple myeloma: a systematic literature review[J]. Blood Cancer J, 2022, 12(3): 45., articleTitle=null, refAbstract=null), Reference(id=1325224543408759217, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=王辰辰, 张倩倩, 李静, 等. 化痰活血方治疗痰瘀痹阻型多发性骨髓瘤疗效及对患者血管内皮生长因子的影响[J]. 陕西中医, 2022, 43(5): 588-591., articleTitle=null, refAbstract=null), Reference(id=1325224543501033906, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=中国医师协会血液科医师分会, 中华医学会血液学分会,中国医师协会多发性骨髓瘤专业委员会. 中国多发性骨髓瘤诊治指南(2015年修订)[J]. 中华内科杂志, 2015, 54(12):1066-1070., articleTitle=null, refAbstract=null), Reference(id=1325224543593308595, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=中华中医药学会. T/CACM 1243-2019 中医肿瘤科临床诊疗指南多发性骨髓瘤[S]. 北京: 中国中医药出版社, 2019., articleTitle=null, refAbstract=null), Reference(id=1325224543673000372, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=徐岳一, 徐勇, 邵晓雁, 等. 海曲泊帕促进多发性骨髓瘤患者自体造血干细胞移植后血小板恢复的疗效与安全性临床研究[J]. 国际输血及血液学杂志, 2024, 47(5): 403-410., articleTitle=null, refAbstract=null), Reference(id=1325224543819801013, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=MAURA F, BERGSAGEL PL. Molecular pathogenesis of multiple myeloma: clinical implications[J]. Hematol Oncol Clin North Am, 2024, 38(2): 267-279., articleTitle=null, refAbstract=null), Reference(id=1325224543882715574, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=高舒荃, 穆娟, 李新, 等. 骨髓可溶性B细胞成熟抗原表达在多发性骨髓瘤患者中作为BCMA CAR-T细胞疗效预测指标的研究[J]. 中华血液学杂志, 2024, 45(4): 378-382., articleTitle=null, refAbstract=null), Reference(id=1325224543954018743, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=江聪法, 鲍伟红, 俞晶晶, 等. 环磷酰胺地塞米松联合硼替佐米化疗对多发性骨髓瘤患者血清及核因子-κB受体活化因子配体的影响[J]. 中国药物与临床, 2025, 25(1): 53-56., articleTitle=null, refAbstract=null), Reference(id=1325224544037904824, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=宫敬智, 张文平, 钱燕芬, 等. 养心定悸颗粒联合化疗治疗多发性骨髓瘤患者临床效果观察[J]. 临床军医杂志, 2024,52(5): 523-525., articleTitle=null, refAbstract=null), Reference(id=1325224544113402297, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=CHARLINSKI G, JURCZYSZYN A. Non-secretory multiple myeloma: diagnosis and management[J]. Adv Clin Exp Med, 2022, 31(1): 95-100., articleTitle=null, refAbstract=null), Reference(id=1325224544188899770, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=叶小锋, 邓全锦, 徐培杰. 化痰活血方联合VCD方案化疗治疗多发性骨髓瘤疗效观察及对免疫功能、炎症因子的影响研究[J]. 新中医, 2024, 56(20): 169-173., articleTitle=null, refAbstract=null), Reference(id=1325224544256008635, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=毛沛沛, 杨琛. 硼替佐米联合地塞米松、来那度胺化疗方案治疗多发性骨髓瘤的疗效和安全性评价[J]. 实用癌症杂志, 2023, 38(3): 502-506., articleTitle=null, refAbstract=null), Reference(id=1325224544331506108, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=MOHTY M, FACON T, MALARD F, et al. A roadmap towards improving outcomes in multiple myeloma[J]. Blood Cancer J, 2024, 14(1): 135., articleTitle=null, refAbstract=null), Reference(id=1325224544390226365, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=董世惠, 范芸, 夏园园, 等. 肾损伤分子1介导游离轻链内吞致近端肾小管上皮细胞损伤[J]. 肾脏病与透析肾移植杂志, 2023, 32(2): 121-127., articleTitle=null, refAbstract=null), Reference(id=1325224544453140926, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=王明辉, 于航, 陈惠娟, 等. 达雷妥尤单抗治疗复发难治性多发性骨髓瘤及对T细胞亚群、炎症因子、肿瘤相关因子的影响[J]. 中国现代医学杂志, 2024, 34(22): 72-77., articleTitle=null, refAbstract=null), Reference(id=1325224544528638399, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=陈明真, 张学亚, 王美娥, 等. 炎症评分与营养-免疫评分对新诊断多发性骨髓瘤患者的预后意义[J]. 中国实验血液学杂志, 2025, 33(4): 1069-1078., articleTitle=null, refAbstract=null), Reference(id=1325224544604135872, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=曹慧, 黄来全, 汪琼, 等. 来那度胺联合硼替佐米、地塞米松治疗多发性骨髓瘤的效果及对免疫功能的影响研究[J]. 中国医药导报, 2024, 21(8): 119-122., articleTitle=null, refAbstract=null), Reference(id=1325224544667050433, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=王晖, 同海宁, 郑研, 等. 多发性骨髓瘤患者的血清PINP、DKK1和SFRP3水平及其临床意义[J]. 广西医学, 2024,46(1): 48-52., articleTitle=null, refAbstract=null), Reference(id=1325224544755130818, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=唐川, 邱玲. 血清葡萄糖调节蛋白78在多发性骨髓瘤病人中的表达及其预后意义[J]. 安徽医药, 2024, 28(9): 1773-1777., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1325224539524833683, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, xref=1., ext=[AuthorCompanyExt(id=1325224539537416596, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539524833683, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Oncology, Lianshui County Central Hospital, Huai'an 223400, Jiangsu Province, China), AuthorCompanyExt(id=1325224539545805205, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539524833683, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.涟水县中医院肿瘤科,江苏 淮安 223400)]), AuthorCompany(id=1325224539625496982, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, xref=2., ext=[AuthorCompanyExt(id=1325224539633885591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539625496982, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Kunshan Central Hospital, Kunshan 215300, Jiangsu Province, China), AuthorCompanyExt(id=1325224539642274200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539625496982, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.昆山市中医院肿瘤科,江苏 昆山 215300)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.02.007, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.02.007, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2026.02.007, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2026.02.007, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1770652800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
化痰活血方治疗痰瘀痹阻型多发性骨髓瘤的效果及对分泌型卷曲相关蛋白、葡萄糖调节蛋白的影响分析
钱芳 1 , 戴安伟 2, *
世界临床药物 | 研究论文 2026,47(2): 157-163
收起
收藏切换
世界临床药物 |研究论文 2026 , 47 (2) : 157 -163
化痰活血方治疗痰瘀痹阻型多发性骨髓瘤的效果及对分泌型卷曲相关蛋白、葡萄糖调节蛋白的影响分析
全屏
[Author(id=1325224539730354586, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1325224539814240668, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, authorId=1325224539730354586, language=EN, stringName=Fang QIAN, firstName=Fang, middleName=null, lastName=QIAN, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.Department of Oncology, Lianshui County Central Hospital, Huai'an 223400, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224539889738141, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, authorId=1325224539730354586, language=CN, stringName=钱芳, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=1, address=1.涟水县中医院肿瘤科,江苏 淮安 223400, bio={"content":"

钱芳,副主任中医师,研究方向:中医中药治疗肿瘤疾病研究。

"}, bioImg=null, bioContent=

钱芳,副主任中医师,研究方向:中医中药治疗肿瘤疾病研究。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224539524833683, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, xref=1., ext=[AuthorCompanyExt(id=1325224539537416596, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539524833683, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.Department of Oncology, Lianshui County Central Hospital, Huai'an 223400, Jiangsu Province, China), AuthorCompanyExt(id=1325224539545805205, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539524833683, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=1.涟水县中医院肿瘤科,江苏 淮安 223400)])]), Author(id=1325224539982012831, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1325224540061704609, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, authorId=1325224539982012831, language=EN, stringName=Anwei DAI, firstName=Anwei, middleName=null, lastName=DAI, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.Department of Oncology, Kunshan Central Hospital, Kunshan 215300, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1325224540162367906, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, authorId=1325224539982012831, language=CN, stringName=戴安伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=2, *, address=2.昆山市中医院肿瘤科,江苏 昆山 215300, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1325224539625496982, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, xref=2., ext=[AuthorCompanyExt(id=1325224539633885591, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539625496982, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.Department of Oncology, Kunshan Central Hospital, Kunshan 215300, Jiangsu Province, China), AuthorCompanyExt(id=1325224539642274200, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1325224538853745040, companyId=1325224539625496982, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=2.昆山市中医院肿瘤科,江苏 昆山 215300)])])]
钱芳1, 戴安伟2, *
作者信息
  • 1.涟水县中医院肿瘤科,江苏 淮安 223400
  • 2.昆山市中医院肿瘤科,江苏 昆山 215300
通讯作者:
戴安伟,主任中医师,研究方向:中医中药治疗疾病研究。
作者简介:

钱芳,副主任中医师,研究方向:中医中药治疗肿瘤疾病研究。

Effect of Huatan Huoxue decoction on multiple myeloma of phlegm-stasis obstruction type and its influence on SFRP3 and GRP78
Fang QIAN1, Anwei DAI2, *
Affiliations
  • 1.Department of Oncology, Lianshui County Central Hospital, Huai'an 223400, Jiangsu Province, China
  • 2.Department of Oncology, Kunshan Central Hospital, Kunshan 215300, Jiangsu Province, China
出版时间: 2026-02-10 doi: 10.13683/j.wph.2026.02.007
文章导航
收藏切换
目的

探讨化痰活血方治疗痰瘀痹阻型多发性骨髓瘤(multiple myeloma,MM)的效果及对分泌型卷曲相关蛋白(secreted frizzled related protein,SFRP)3、葡萄糖调节蛋白(glucose regulatory protein,GRP)78的影响。

方法

选择2022年1月至2024年12月涟水县中医院收治的MM患者作为研究对象,以简单随机法分为观察组62例(化疗+来那度胺+化痰活血方)和对照组61例(化疗+来那度胺)。两组均连续治疗3个周期。本研究主要指标为临床总有效率;次要指标包含治疗1及3个周期后的SFRP3、GRP78及炎症因子水平,以及治疗3个周期后的疼痛视觉模拟评分(visual analogue scale,VAS)、卡氏功能状态评分(Karnofsky performance status,KPS)、日常生活活动(activity of daily living,ADL)量表;安全性指标为不良反应发生率。

结果

观察组治疗总有效率为明显高于对照组(93.55% vs. 80.33%,P<0.05)。治疗1及3个周期后,两组血清SFRP3、GRP78水平均较治疗前降低(P<0.05),且观察组低于对照组(P<0.05);两组血清白介素(interleukin,IL)-6、IL-17、转化生长因子-β水平均较治疗前降低(P<0.05),且观察组低于对照组(P<0.05)。治疗3个周期后,两组VAS评分均较治疗前降低(P<0.05),且观察组低于对照组(P<0.05),KPS及ADL评分均较治疗前升高(P<0.05),且观察组高于对照组(P<0.05)。观察组不良反应发生率低于对照组(P<0.05)。

结论

化痰活血方可帮助痰瘀痹阻型MM患者症状缓解,延缓疾病进展,改善SFRP3、GRP78及炎症因子水平,且不增加不良反应发生率。

多发性骨髓瘤  /  化痰活血方  /  化疗  /  分泌型卷曲相关蛋白3  /  葡萄糖调节蛋白78
Objective

To investigate the efficacy of Huatan Huoxue decoction on multiple myeloma(MM) of phlegm-stasis obstruction type and its influence on secreted frizzled related protein(SFRP) 3 and glucose regulatory protein(GRP) 78.

Methods

The patients with MM admitted to Lianshui county central hospital from January 2022 to December 2024 were selected as the research subjects. They were randomly divided into the observation group(62 cases, treated with chemotherapy+ilarradine+Huatan Huoxue decoction) and the control group(61 cases, treated with chemotherapy+ilarradine) using the simple random method. Both groups were treated continuously for 3 cycles. The main indicator of this study was the clinical total effective rate. The secondary indicators included the levels of SFRP3, GRP78 and inflammatory factors after 1 and 3 cycles of treatment, as well as the visual analogue scale(VAS) for pain, Karnofsky performance status(KPS), and activity of daily living(ADL) scale after 3 cycles of treatment. The safety indicator was the incidence of adverse reactions.

Results

The total effective rate of the observation group was significantly higher than that of the control group(93.55% vs. 80.33%, P<0.05). After 1 and 3 cycles of treatment, the serum levels of SFRP3 and GRP78 in both groups were lower than those before treatment(P<0.05), and the levels in the observation group were lower than those in the control group(P<0.05). The serum levels of interleukin(IL)-6, IL-17 and transforming growth factor-β in both groups were lower than those before treatment(P<0.05), and the levels in the observation group were lower than those in the control group(P<0.05). After 3 cycles of treatment, the VAS scores of both groups were lower than those before treatment(P<0.05), and the score of the observation group was lower than that of the control group(P<0.05). The KPS and ADL scores of both groups were higher than those before treatment(P<0.05), and the scores of the observation group were higher than those of the control group(P<0.05). The incidence of adverse reactions in the observation group was lower than that in the control group(P<0.05).

Conclusion

The formula for resolving phlegm and promoting blood circulation can help alleviate symptoms, delay disease progression, improve SFRP3, GRP78 and inflammatory factors levels, withoutt increasing the incidence of adverse reactions in patients with phlegm stasis obstruction type MM.

multiple myeloma  /  Huatan Huoxue decoction  /  chemotherapy  /  secreted frizzled related protein 3  /  glucose regulatory protein 78
钱芳, 戴安伟. 化痰活血方治疗痰瘀痹阻型多发性骨髓瘤的效果及对分泌型卷曲相关蛋白、葡萄糖调节蛋白的影响分析. 世界临床药物, 2026 , 47 (2) : 157 -163 . DOI: 10.13683/j.wph.2026.02.007
Fang QIAN, Anwei DAI. Effect of Huatan Huoxue decoction on multiple myeloma of phlegm-stasis obstruction type and its influence on SFRP3 and GRP78[J]. World Clinical Drug, 2026 , 47 (2) : 157 -163 . DOI: 10.13683/j.wph.2026.02.007

参考文献 引证文献
排序方式:
[1]
王国蓉, 杨光忠, 耿传营, 等. 依托泊苷联合G-CSF与环磷酰胺联合G-CSF在多发性骨髓瘤患者中进行自体外周血干细胞动员的比较[J]. 中华血液学杂志, 2024, 45(4): 351-356.
[2]
谢适意, 于珍, 魏晓晶, 等. 细胞周期蛋白依赖性激酶4/6抑制剂对多发性骨髓瘤细胞B细胞成熟抗原和程序性死亡受体配体1表达的影响[J]. 中华实用诊断与治疗杂志, 2024,38(6): 546-551.
[3]
HANAMURA I. Multiple myeloma with high-risk cytogenetics and its treatment approach[J]. Int J Hematol, 2022, 115(6): 762-777.
[4]
BLADE J, BEKSAC M, CAERS J, et al. Extramedullary disease in multiple myeloma: a systematic literature review[J]. Blood Cancer J, 2022, 12(3): 45.
[5]
王辰辰, 张倩倩, 李静, 等. 化痰活血方治疗痰瘀痹阻型多发性骨髓瘤疗效及对患者血管内皮生长因子的影响[J]. 陕西中医, 2022, 43(5): 588-591.
[6]
中国医师协会血液科医师分会, 中华医学会血液学分会,中国医师协会多发性骨髓瘤专业委员会. 中国多发性骨髓瘤诊治指南(2015年修订)[J]. 中华内科杂志, 2015, 54(12):1066-1070.
[7]
中华中医药学会. T/CACM 1243-2019 中医肿瘤科临床诊疗指南多发性骨髓瘤[S]. 北京: 中国中医药出版社, 2019.
[8]
徐岳一, 徐勇, 邵晓雁, 等. 海曲泊帕促进多发性骨髓瘤患者自体造血干细胞移植后血小板恢复的疗效与安全性临床研究[J]. 国际输血及血液学杂志, 2024, 47(5): 403-410.
[9]
MAURA F, BERGSAGEL PL. Molecular pathogenesis of multiple myeloma: clinical implications[J]. Hematol Oncol Clin North Am, 2024, 38(2): 267-279.
[10]
高舒荃, 穆娟, 李新, 等. 骨髓可溶性B细胞成熟抗原表达在多发性骨髓瘤患者中作为BCMA CAR-T细胞疗效预测指标的研究[J]. 中华血液学杂志, 2024, 45(4): 378-382.
[11]
江聪法, 鲍伟红, 俞晶晶, 等. 环磷酰胺地塞米松联合硼替佐米化疗对多发性骨髓瘤患者血清及核因子-κB受体活化因子配体的影响[J]. 中国药物与临床, 2025, 25(1): 53-56.
[12]
宫敬智, 张文平, 钱燕芬, 等. 养心定悸颗粒联合化疗治疗多发性骨髓瘤患者临床效果观察[J]. 临床军医杂志, 2024,52(5): 523-525.
[13]
CHARLINSKI G, JURCZYSZYN A. Non-secretory multiple myeloma: diagnosis and management[J]. Adv Clin Exp Med, 2022, 31(1): 95-100.
[14]
叶小锋, 邓全锦, 徐培杰. 化痰活血方联合VCD方案化疗治疗多发性骨髓瘤疗效观察及对免疫功能、炎症因子的影响研究[J]. 新中医, 2024, 56(20): 169-173.
[15]
毛沛沛, 杨琛. 硼替佐米联合地塞米松、来那度胺化疗方案治疗多发性骨髓瘤的疗效和安全性评价[J]. 实用癌症杂志, 2023, 38(3): 502-506.
[16]
MOHTY M, FACON T, MALARD F, et al. A roadmap towards improving outcomes in multiple myeloma[J]. Blood Cancer J, 2024, 14(1): 135.
[17]
董世惠, 范芸, 夏园园, 等. 肾损伤分子1介导游离轻链内吞致近端肾小管上皮细胞损伤[J]. 肾脏病与透析肾移植杂志, 2023, 32(2): 121-127.
[18]
王明辉, 于航, 陈惠娟, 等. 达雷妥尤单抗治疗复发难治性多发性骨髓瘤及对T细胞亚群、炎症因子、肿瘤相关因子的影响[J]. 中国现代医学杂志, 2024, 34(22): 72-77.
[19]
陈明真, 张学亚, 王美娥, 等. 炎症评分与营养-免疫评分对新诊断多发性骨髓瘤患者的预后意义[J]. 中国实验血液学杂志, 2025, 33(4): 1069-1078.
[20]
曹慧, 黄来全, 汪琼, 等. 来那度胺联合硼替佐米、地塞米松治疗多发性骨髓瘤的效果及对免疫功能的影响研究[J]. 中国医药导报, 2024, 21(8): 119-122.
[21]
王晖, 同海宁, 郑研, 等. 多发性骨髓瘤患者的血清PINP、DKK1和SFRP3水平及其临床意义[J]. 广西医学, 2024,46(1): 48-52.
[22]
唐川, 邱玲. 血清葡萄糖调节蛋白78在多发性骨髓瘤病人中的表达及其预后意义[J]. 安徽医药, 2024, 28(9): 1773-1777.
2026年第47卷第2期
58
15
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2026.02.007
  • 接收时间:2025-09-28
  • 首发时间:2026-11-05
  • 出版时间:2026-02-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-09-28
基金
作者信息
    1.涟水县中医院肿瘤科,江苏 淮安 223400
    2.昆山市中医院肿瘤科,江苏 昆山 215300

通讯作者:

戴安伟,主任中医师,研究方向:中医中药治疗疾病研究。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2026.02.007
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏